Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
JACC. Case Reports|February 24, 2026
Paradoxical Pulmonary Congestion After Mavacamten in Obstructive HCM: A Case Illustrating Hemodynamic TransitionNoriaki Tabata, Yasuhiro Izumiya, Noriko Nomura, et al.
Journal of Echocardiography|December 27, 2024
Echocardiographic findings of patients with transthyretin amyloid cardiomyopathyHiroki Usuku, Fumi Oike, Naoto Kuyama, et al.
Circulation Reports|August 11, 2025
Real-World Clinical Evidence With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy - A Contemporary ReviewYasuhiro Izumiya, Naoto Kuyama, Shinsuke Hanatani, et al.
Internal Medicine (Tokyo, Japan)|August 4, 2017
Multiple Giant Coronary Artery AneurysmsHiroki Usuku, Sunao Kojima, Naoto Kuyama, et al.
Journal of Cardiology Cases|June 3, 2024
Coexisting transthyretin and atrial natriuretic peptide amyloid on left atrium in transthyretin amyloid cardiomyopathyNaoto Kuyama, Seiji Takashio, Kosuke Nakamura, et al.
JACC. Case Reports|June 20, 2026
Postpartum Aortic Dissection Without Aortic Dilation in a Woman With an ACTA2 Gene MutationMiyu Umeda, Fumi Oike, Yuichiro Shirahama, et al.
JACC. Case Reports|September 9, 2025
Right Ventricle-Dominant Cardiac Sarcoidosis Diagnosed Using a Multimodal ApproachTakahide Matsuda, Naoto Kuyama, Yuichiro Tsuruta, et al.
Heart and Vessels|November 5, 2024
5-Aminolevulinic acid combined with ferrous iron ameliorates myocardial ischemia/reperfusion injury by increasing heme oxygenase-1Nobuhiro Nakanishi, Koichi Kaikita, Yu Oimatsu, et al.
JACC. Case Reports|December 18, 2024
Long-Term Outcomes of Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy in Two PatientsNaoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, et al.
Pageof 5